191 results
Page 8 of 10
DEFA14A
bau1v7 je
2 May 19
Additional proxy soliciting materials
7:38am
8-K
EX-99.1
6paorkp 6d
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-10.1
51d9fnmx8
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
ddy3ag5s7jxi 5rcy
11 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:42pm
DEFA14A
3tsbg0c a0fo8gp
3 Jul 18
Additional proxy soliciting materials
4:15pm
DEFA14A
bl8ve5p4hd1tberup
29 May 18
Additional proxy soliciting materials
4:32pm
PRE 14A
1844c vbz
17 May 18
Preliminary proxy
5:21pm
8-K
EX-10.1
qub75aksd28 nse
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am
8-K
EX-4.1
ni1942
13 Apr 18
EyeGate Announces $11.25 Million Public Offering
12:00am